Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Febuxostat for Ambulatory Blood Pressure in Hyperuricemia and Hypertension
NCT01496469Phase 2Completed
- Sponsor
- Takeda
- Start
- Feb 2012
- Primary completion
- Aug 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of febuxostat in hypertension (HTN), sponsored by Takeda. Started Feb 2012; status: completed.
02
Drugs
febuxostat
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT01496469.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01496469.